Indaptus Therapeutics files S-8 form
- Filed on 2026-10-05
- Registers 13,324,232 shares of common stock
- Incorporates 2026 Equity Incentive Plan
Every EDGAR filing for Indaptus Therapeutics, Inc. (INDP), newest first, with AI summaries and stories.
Next: earnings expected ~Nov 13 · 10-Q expected ~Nov 13 (deadline Nov 16)
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
Ownership stake disclosure by SINO LION VENTURES Ltd (amended)
SINO LION VENTURES Ltd, filed by
Ownership stake disclosure by Junyi Dai (amended)
Junyi Dai, filed by
Ownership stake disclosure by Ting Yang (amended)
Ting Yang, filed by
Ownership stake disclosure by Yun Yao (amended)
Yun Yao, filed by
Ownership stake disclosure by Yun Yao (amended)
Yun Yao, filed by
Qinglai Lu, new insider at INDP
Qinglai Lu, reporting
Ownership stake disclosure by YA II PN, Ltd. (amended)
YA II PN, Ltd., filed by
Yun Yao, new insider at INDP
Yun Yao, reporting
Ownership stake disclosure by Yun Yao
Yun Yao, filed by
Ownership stake disclosure by David E. Lazar (amended)
David E. Lazar, filed by
David E. Lazar, insider filing for INDP
David E. Lazar, reporting
Ownership stake disclosure by David E. Lazar
David E. Lazar, filed by
Jerome D Jabbour, insider filing for INDP
Jerome D Jabbour, reporting
Matthew Charles McMurdo, new insider at INDP
Matthew Charles McMurdo, reporting
Jeffrey A Meckler, insider filing for INDP
Jeffrey A Meckler, reporting
Avraham Ben-Tzvi, insider filing for INDP
Avraham Ben-Tzvi, reporting